Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1999
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2302155A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0902007A1 Chalcone derivatives and drugs containing the same
03/17/1999EP0901521A1 Antigenic modulation of cells
03/17/1999EP0901465A1 Compounds with anti-inflammatory and immunosuppressive activities
03/17/1999EP0901464A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
03/17/1999EP0901462A1 Bi-aromatic compounds, compositions containing them and uses
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901375A1 Dhea combination therapy
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0661975B1 Transdermal treatment of urticaria USING OPTICALLY PURE (+) CETIRIZINE
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1042540C Process for preparation of 4-amino 'delta' 4-3-ketosteroids via 4-nitro-'delta' 4-3-ketostoroids
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5882901 Sialylating specified oligosaccharide with sialyltransferase, fucosylating with fucosyltransferase
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882871 Saliva binding protein
03/16/1999US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources
03/16/1999US5882648 Methods of disease inhibition using acid polysaccharides extracted from nutshells
03/16/1999US5882645 Peptide compounds
03/16/1999US5882328 Method to prevent transplant rejection
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2160140C Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
03/16/1999CA2150709C Pyrazolopyrimidines
03/16/1999CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011285A1 Composition to protect a mammal against bartonella henselae infection
03/11/1999WO1999011284A1 Oral vaccine
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011263A1 Combination therapy comprising amlodipine and a statin compound
03/11/1999WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900841A1 LAG-3 splice variants
03/10/1999EP0900375A1 Pharmaceutical grade botanical drugs
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900232A1 High molecular weight surface proteins of non-typeable haemophilus
03/10/1999EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/10/1999EP0900212A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
03/10/1999EP0900203A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900078A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
03/10/1999EP0735898B1 Vaccines
03/10/1999EP0733049B1 Tricyclic derivatives and their use in pharmaceuticals
03/10/1999EP0722438B1 Hydroxamic acid derivatives as inhibitors of cytokine production
03/10/1999EP0703783A4 Hla-a2.1 binding peptides and their uses
03/10/1999EP0548214B1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS
03/10/1999CN1210470A Vacciness against varicella zoster virus gene 63 product
03/10/1999CN1210467A Formulation
03/10/1999CN1210465A Method of treatment and pharmaceutical composition
03/09/1999US5880280 Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880124 For treatment of hypotension
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 1172